top of page
AboutUs.jpeg

About Us

Our Mission

Vetana’s mission is to improve the lives of animals who suffer from inflammatory diseases. Our therapy supports the intrinsic mechanisms already present in the body to control inflammation. Our lead program delivers Interleukin-10, nature’s own anti-inflammatory agent, directly into areas of inflammation such as joints with osteoarthritis. Reducing joint inflammation leads to less pain and improved mobility.

 

We are a team of drug development experts with decades of experience in bringing new products to patients. We share a deep passion for the well-being of animals and are devoted to working on novel therapies that we hope will make meaningful improvements in their lives.

Meet The Team

steve_headshot.png

Steve Collins, M.D., Ph.D.

President and Executive Chairman

pbm2.png

Gary Massengill

Director, Product Development and Regulatory

(PBM Capital Group)

ray_headshot.png

Ray Chavez, Ph.D.

VP, Research & Development

shannon_headshot.png

Shannon Hall

Project Management

(PBM Capital Group)

jayson_headshot.png

Jayson Rieger

Chief Operating Officer

pbm3headshot.png

David Glover

Director, Research and Development

(PBM Capital Group)

Our Board of Directors

paul-headshot.png
Paul Manning

sean_headhsot.png
Sean Stalfort

steve_headshot.png
Stephen D. Collins,
MD, Ph.D.

jayson_headshot.png
Jayson Rieger, Ph.D., MBA

© 2022 by Vetana Animal Health, Inc.

bottom of page